论文部分内容阅读
目的:探讨米索前列醇联合缩宫素治疗产后出血的临床效果。方法:以我院收治的42例产后出血患者为研究对象。随机分为观察组与对照组,每组21例,对照组患者采取单纯缩宫素治疗,观察组患者接受米索前列醇联合缩宫素进行治疗,比较两组患者第三产程时间及产后0.5h、1h、2h出血量。结果:观察组患者第三产程时间为(7.5±2.8)min,产后0.5h、1h、2h出血量分别为(122.3±15.4)ml、(150.1±28.7)ml、(179.6±37.7)ml,与对照组比较存在显著差异,P<0.05。结论:产后出血应用米索前列醇联合缩宫素治疗,可显著降低第三产程及产后出血量,较单纯应用缩宫素有明显优势,且安全性较高。
Objective: To investigate the clinical effect of misoprostol combined with oxytocin in the treatment of postpartum hemorrhage. Methods: 42 cases of postpartum hemorrhage treated in our hospital were studied. Were randomly divided into observation group and control group, 21 cases in each group, the control group patients treated with simple oxytocin, the observation group received misoprostol combined with oxytocin for treatment, comparing the two groups of patients in the third stage of labor time and postpartum 0.5 h, 1h, 2h bleeding. Results: The duration of the third stage of labor was (7.5 ± 2.8) min in the observation group and (122.3 ± 15.4) ml, (150.1 ± 28.7) ml and (179.6 ± 37.7) ml in the postoperative 0.5h, 1h and 2h The control group there is a significant difference, P <0.05. Conclusion: The application of misoprostol combined with oxytocin postpartum hemorrhage can significantly reduce the third stage of labor and postpartum hemorrhage, compared with the simple application of oxytocin has obvious advantages, and high safety.